Assessing depression levels in patients with coronary artery disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to estimate the prevalence and severity of depression among patients diagnosed with coronary artery disease (CAD) in Baghdad, Iraq. Participants will complete the PHQ-9 questionnaire to assess their depressive symptoms and provide demographic and clinical information to explore potential correlations with depression. The study seeks to identify how common depression is in CAD patients and whether specific factors are associated with higher levels of depression. By understanding these relationships, the study aims to shed light on the impact of depression on CAD outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with coronary artery disease (confirmed through clinical, imaging, or procedural evidence).
* Receiving care at designated hospitals in Baghdad.
* Able to understand and complete the PHQ-9 questionnaire independently or with minimal assistance.
* Consents to participate in the study.

Exclusion Criteria:

* Patients with a history of severe psychiatric disorders unrelated to depression (e.g., schizophrenia, bipolar disorder).
* Patients with cognitive impairments or neurological conditions affecting their ability to complete the questionnaire.
* Those currently hospitalized for acute cardiac events (e.g., myocardial infarction) requiring intensive care.
* Individuals unwilling to provide informed consent.

Where it's running

• College of Medicine - Al-Nahrain University
  Baghdad, Iraq Recruiting

Study contacts

• Study coordinator: Abdul-Ilah R. Khamis
• Email: allaabed987@ced.nahrainuniv.edu.iq
• Phone: +9647838571013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression

  This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07896343

• Health education program to help depression in older adults and caregivers in Ho Chi Minh City

  A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.

  Recruiting University of Medicine and Pharmacy at Ho Chi Minh City · Ho Chi Minh City, Cho Lon · NCT07877571

• Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep

  This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.

  Recruiting University of Oxford · Oxford, Oxfordshire · NCT07848477

• Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety

  This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.

  Recruiting Singula Health, Inc. · Brentwood, New York and 1 other locations · NCT07834684

• Medically tailored groceries to help depression in people with food insecurity

  This trial tests whether giving medically tailored groceries for six months can reduce depressive symptoms in adults who have depression and struggle with access to food.

  Recruiting at 2 sites University of Massachusetts, Worcester · Worcester, Massachusetts and 2 other locations · NCT07779707

• Health and Work Ability After Inpatient Treatment for Stress-Related Disorders: Follow-Up of the HARMODI Cohort

  This study follows people who had inpatient treatment for stress-related disorders to see how their health and ability to work change over the next three years and what factors help them return to work.

  Recruiting Clinica Holistica Engiadina · Süs and 1 other locations · NCT07757997

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.